Langley, R., D. Thaci, A. . Blauvelt, T.-F. Tsai, M. . Miller, J. Yu, Y.-K. . Shen, Y. You, Y.-W. Yang, K. . Papp, L. Puig, and P. Foley. “Low Risk of Serious Infections and Infections of Interest in Psoriasis Patients Treated With Guselkumab (GUS) for up to 5 Years in VOYAGE (VOY) 1&Amp;2 Phase 3 Trials”. SKIN The Journal of Cutaneous Medicine, vol. 6, no. 2, Mar. 2022, p. s1, doi:10.25251/skin.6.supp.1.